# ANRS 12406 EvvA Study

> **NCT04593979** · — · UNKNOWN · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 289 (estimated)

## Conditions studied

- HIV-1-infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04593979
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-15
- **Primary completion:** 2022-01-14
- **Final completion:** 2022-01-14
- **Target enrollment:** 289 (ESTIMATED)
- **Last updated:** 2021-04-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04593979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04593979, "ANRS 12406 EvvA Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04593979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*